Verition Fund Management LLC purchased a new position in Sabra Health Care REIT, Inc. (NASDAQ:SBRA - Get Rating) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 26,968 shares of the real estate investment trust's stock, valued at approximately $354,000.
→ Traders Use A.I. to Conquer Volatility? (From Vantage Point)
Several other institutional investors and hedge funds have also made changes to their positions in SBRA. Deutsche Bank AG raised its stake in Sabra Health Care REIT by 161.6% in the 2nd quarter. Deutsche Bank AG now owns 5,097,445 shares of the real estate investment trust's stock worth $71,210,000 after acquiring an additional 3,148,985 shares during the last quarter. Millennium Management LLC increased its holdings in shares of Sabra Health Care REIT by 3,773.6% in the second quarter. Millennium Management LLC now owns 1,998,167 shares of the real estate investment trust's stock valued at $27,914,000 after purchasing an additional 1,946,583 shares during the period. Russell Investments Group Ltd. increased its holdings in shares of Sabra Health Care REIT by 290.8% in the third quarter. Russell Investments Group Ltd. now owns 2,487,838 shares of the real estate investment trust's stock valued at $32,527,000 after purchasing an additional 1,851,243 shares during the period. State Street Corp raised its stake in shares of Sabra Health Care REIT by 18.1% in the first quarter. State Street Corp now owns 12,035,766 shares of the real estate investment trust's stock worth $179,213,000 after purchasing an additional 1,840,939 shares during the last quarter. Finally, Invesco Ltd. lifted its holdings in shares of Sabra Health Care REIT by 59.3% during the first quarter. Invesco Ltd. now owns 2,732,970 shares of the real estate investment trust's stock worth $40,695,000 after purchasing an additional 1,017,252 shares during the period. 87.20% of the stock is currently owned by institutional investors and hedge funds.
Several brokerages recently weighed in on SBRA. JMP Securities downgraded shares of Sabra Health Care REIT from an "outperform" rating to a "market perform" rating in a report on Tuesday, December 13th. Bank of America lowered shares of Sabra Health Care REIT from a "neutral" rating to an "underperform" rating and lowered their price target for the company from $15.00 to $13.00 in a report on Monday, November 14th. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating and one has assigned a buy rating to the company's stock. According to MarketBeat.com, Sabra Health Care REIT presently has a consensus rating of "Hold" and an average price target of $14.50.
SBRA stock opened at $11.66 on Wednesday. Sabra Health Care REIT, Inc. has a one year low of $11.44 and a one year high of $16.60. The company has a debt-to-equity ratio of 0.82, a quick ratio of 3.27 and a current ratio of 3.27. The firm's fifty day moving average is $12.88 and its 200 day moving average is $13.14. The firm has a market cap of $2.70 billion, a PE ratio of -34.29 and a beta of 1.30.
The firm also recently announced a quarterly dividend, which was paid on Tuesday, February 28th. Stockholders of record on Monday, February 13th were given a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 10.29%. The ex-dividend date was Friday, February 10th. Sabra Health Care REIT's dividend payout ratio (DPR) is presently -352.94%.
Sabra Health Care REIT, Inc engages in managing and investing in healthcare-related real estate properties. It focuses on the acquisition, financing and owning real estate property to be leased to third party tenants in the healthcare sector. The company was founded on May 10, 2010 and is headquartered in Irvine, CA.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]
Before you consider Sabra Health Care REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Health Care REIT wasn't on the list.
While Sabra Health Care REIT currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
